Guy Hermans joined Sapreme as CEO in 2020. He brings in 20 years of experience in platform company development experience, with a focus on antibody discovery and early development, as well as technology development.Previously, he led internal technology and product development at Isogenica and drove the scientific interactions with its licensees. The re-engineering of the company and its technologies portfolio allowed it to become consistently profitable, and multiple leads entered the clinic since.Prior to this, Guy held a number of positions of increasing responsibility at Ablynx, growing with the company from startup to and beyond IPO..